The scientists at The Scripps Translational Science Institute have released a mobile app that utilizes your pre-existing 23andMe data to calculate your genomic risk for coronary disease and response to statin therapy. The information is being provided as part of a research study. We are doing closed beta testing, you can sign up here:
More information describing the app and genetic risk score in our biorxiv manuscript here:
As long as you have pre-existing 23andMe data, the app will pull your data automatically via an API and calculate your score. The app currently only works with iOS devices.